Cargando…
Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands
[Image: see text] Toll-like receptors (TLRs) are key pathogen sensors of the immune system. Their activation results in the production of cytokines, chemokines, and costimulatory molecules that are crucial for innate and adaptive immune responses. In recent years, specific (sub)-cellular location an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303972/ https://www.ncbi.nlm.nih.gov/pubmed/32510940 http://dx.doi.org/10.1021/acs.bioconjchem.0c00237 |
_version_ | 1783548170540679168 |
---|---|
author | van de Graaff, Michel J. Oosenbrug, Timo Marqvorsen, Mikkel H. S. Nascimento, Clarissa R. de Geus, Mark A. R. Manoury, Bénédicte Ressing, Maaike E. van Kasteren, Sander I. |
author_facet | van de Graaff, Michel J. Oosenbrug, Timo Marqvorsen, Mikkel H. S. Nascimento, Clarissa R. de Geus, Mark A. R. Manoury, Bénédicte Ressing, Maaike E. van Kasteren, Sander I. |
author_sort | van de Graaff, Michel J. |
collection | PubMed |
description | [Image: see text] Toll-like receptors (TLRs) are key pathogen sensors of the immune system. Their activation results in the production of cytokines, chemokines, and costimulatory molecules that are crucial for innate and adaptive immune responses. In recent years, specific (sub)-cellular location and timing of TLR activation have emerged as parameters for defining the signaling outcome and magnitude. To study the subtlety of this signaling, we here report a new molecular tool to control the activation of TLR2 via “click-to-release”-chemistry. We conjugated a bioorthogonal trans-cyclooctene (TCO) protecting group via solid support to a critical position within a synthetic TLR2/6 ligand to render the compound unable to initiate signaling. The TCO-group could then be conditionally removed upon addition of a tetrazine, resulting in restored agonist activity and TLR2 activation. This approach was validated on RAW264.7 macrophages and various murine primary immune cells as well as human cell line systems, demonstrating that TCO-caging constitutes a versatile approach for generating chemically controllable TLR2 agonists. |
format | Online Article Text |
id | pubmed-7303972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-73039722020-06-19 Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands van de Graaff, Michel J. Oosenbrug, Timo Marqvorsen, Mikkel H. S. Nascimento, Clarissa R. de Geus, Mark A. R. Manoury, Bénédicte Ressing, Maaike E. van Kasteren, Sander I. Bioconjug Chem [Image: see text] Toll-like receptors (TLRs) are key pathogen sensors of the immune system. Their activation results in the production of cytokines, chemokines, and costimulatory molecules that are crucial for innate and adaptive immune responses. In recent years, specific (sub)-cellular location and timing of TLR activation have emerged as parameters for defining the signaling outcome and magnitude. To study the subtlety of this signaling, we here report a new molecular tool to control the activation of TLR2 via “click-to-release”-chemistry. We conjugated a bioorthogonal trans-cyclooctene (TCO) protecting group via solid support to a critical position within a synthetic TLR2/6 ligand to render the compound unable to initiate signaling. The TCO-group could then be conditionally removed upon addition of a tetrazine, resulting in restored agonist activity and TLR2 activation. This approach was validated on RAW264.7 macrophages and various murine primary immune cells as well as human cell line systems, demonstrating that TCO-caging constitutes a versatile approach for generating chemically controllable TLR2 agonists. American Chemical Society 2020-06-08 2020-06-17 /pmc/articles/PMC7303972/ /pubmed/32510940 http://dx.doi.org/10.1021/acs.bioconjchem.0c00237 Text en Copyright © 2020 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes. |
spellingShingle | van de Graaff, Michel J. Oosenbrug, Timo Marqvorsen, Mikkel H. S. Nascimento, Clarissa R. de Geus, Mark A. R. Manoury, Bénédicte Ressing, Maaike E. van Kasteren, Sander I. Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands |
title | Conditionally Controlling Human TLR2 Activity via
Trans-Cyclooctene Caged Ligands |
title_full | Conditionally Controlling Human TLR2 Activity via
Trans-Cyclooctene Caged Ligands |
title_fullStr | Conditionally Controlling Human TLR2 Activity via
Trans-Cyclooctene Caged Ligands |
title_full_unstemmed | Conditionally Controlling Human TLR2 Activity via
Trans-Cyclooctene Caged Ligands |
title_short | Conditionally Controlling Human TLR2 Activity via
Trans-Cyclooctene Caged Ligands |
title_sort | conditionally controlling human tlr2 activity via
trans-cyclooctene caged ligands |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303972/ https://www.ncbi.nlm.nih.gov/pubmed/32510940 http://dx.doi.org/10.1021/acs.bioconjchem.0c00237 |
work_keys_str_mv | AT vandegraaffmichelj conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT oosenbrugtimo conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT marqvorsenmikkelhs conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT nascimentoclarissar conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT degeusmarkar conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT manourybenedicte conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT ressingmaaikee conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands AT vankasterensanderi conditionallycontrollinghumantlr2activityviatranscyclooctenecagedligands |